Covid-19: What is the evidence for the antiviral molnupiravir?

What is molnupiravir?Molnupiravir (marketed as Lagevrio) is an antiviral drug, slightly modified from a compound known as NHC (β-d-N4-hydroxycytidine) that a team at Emory University in Atlanta,…

Read Original Article: Covid-19: What is the evidence for the antiviral molnupiravir? »